The Company is involved in drug discovery focused on the discovery and development of new therapeutic drugs for the treatment of allergic rhinitis (hay fever) nad other chronic respiratory and inflammatory diseases.
08/05/12
Posting of Annual Report01/05/12
Verona Pharma appoints new CEO05/04/12
Verona Pharma - Preliminary Unaudited Results09/03/12
Verona Pharma - First UK RPL554 anti-inflammator31/01/12
Total Voting Rights16/01/12
Notification of Major Interest in Shares05/01/12
Result of General Meeting04/01/12
Total Voting Rights08/12/11
Completion of GBP3.25 million placing25/11/11
Holding(s) in Verona Pharma09/03/12
Verona Pharma to start clinical trials on COPD drug in UK within months10/11/11
Verona Pharma reports positive results from COPD trial of its lead drug17/08/11
Verona Pharma reports positive results from Phase II study of lead drug26/11/10
Verona Pharma starts Asthma drug trial08/12/09
Verona Pharma to raise £3 million for Hay fever Therapy
Copyright © Proactiveinvestors.co.uk, 2012. All Rights Reserved Design & Development: Tehnicom Computers
